Comment on

• Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure.

  Deeks SG, Grant RM, Beatty GW, Horton C, Detmer J, Eastman S. Deeks SG, et al. AIDS. 1998 Jul 9;12(10):F97-102. doi: 10.1097/00002030-199810000-00002. AIDS. 1998. PMID: 9677159
• Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavir.

  Tebas P, Patick AK, Kane EM, Klebert MK, Simpson JH, Erice A, Powderly WG, Henry K. Tebas P, et al. AIDS. 1999 Feb 4;13(2):F23-8. doi: 10.1097/00002030-199902040-00002. AIDS. 1999. PMID: 10202820 Clinical Trial.
• Efficacy of a five-drug combination including ritonavir, saquinavir and efavirenz in patients who failed on a conventional triple-drug regimen: phenotypic resistance to protease inhibitors predicts outcome of therapy.

  Piketty C, Race E, Castiel P, Belec L, Peytavin G, Si-Mohamed A, Gonzalez-Canali G, Weiss L, Clavel F, Kazatchkine MD. Piketty C, et al. AIDS. 1999 Jul 30;13(11):F71-7. doi: 10.1097/00002030-199907300-00001. AIDS. 1999. PMID: 10449277 Clinical Trial.